Molecular Partners Ag股价重挫11.23% 市值跌319.45万美元

自选股智能写手04-19

北京时间2024年04月19日23时25分，Molecular Partners Ag（MOLN.us）股票出现异动，股价大幅下挫11.23%。截至发稿，该股报3.32美元/股，成交量5704股，换手率0.02%，振幅3.61%。最近的财报数据显示，该股实现营业收入7.83百万美元，净利润-68.97百万美元，每股收益-2.10美元，毛利--，市盈率-1.61倍。机构评级方面，在所有5家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2428266556?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-19 23:25","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2428266556","market":"us","top_or_hot":-1,"title":"Molecular Partners Ag股价重挫11.23% 市值跌319.45万美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月19日23时25分，Molecular Partners Ag（MOLN.us）股票出现异动，股价大幅下挫11.23%。截至发稿，该股报3.32美元/股，成交量5704股，换手率0.02%，振幅3.61%。最近的财报数据显示，该股实现营业收入7.83百万美元，净利润-68.97百万美元，每股收益-2.10美元，毛利--，市盈率-1.61倍。机构评级方面，在所有5家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923254887e822b1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Molecular Partners Ag股价重挫11.23% 市值跌319.45万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMolecular Partners Ag股价重挫11.23% 市值跌319.45万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-19 23:25 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923254887e822b1&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月19日23时25分，Molecular Partners Ag（MOLN.us）股票出现异动，股价大幅下挫11.23%。截至发稿，该股报3.32美元/股，成交量5704股，换手率0.02%，振幅3.61%。最近的财报数据显示，该股实现营业收入7.83百万美元，净利润-68.97百万美元，每股收益-2.10美元，毛利--，市盈率-1.61倍。机构评级方面，在所有5家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923254887e822b1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923254887e822b1&s=b","article_id":"2428266556","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923254887e822b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2428266556","pubTimestamp":1713540347,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月19日23时25分，Molecular Partners Ag股票出现异动，股价大幅下挫11.23%。截至发稿，该股报3.32美元/股，成交量5704股，换手率0.02%，振幅3.61%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.13%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","BK4139":"生物科技","MOLN":"Molecular Partners AG"},"translate_title":"Molecular Partners Ag's stock price plummeted 11.23%, and its market value fell by $3.1945 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MOLN":0.9},"content_text":"北京时间2024年04月19日23时25分，Molecular Partners Ag（MOLN.us）股票出现异动，股价大幅下挫11.23%。截至发稿，该股报3.32美元/股，成交量5704股，换手率0.02%，振幅3.61%。最近的财报数据显示，该股实现营业收入7.83百万美元，净利润-68.97百万美元，每股收益-2.10美元，毛利--，市盈率-1.61倍。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，60%的券商给予持有建议，20%的券商给予卖出建议。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 (To Pur Com)、Chromocell Therapeutics Corporation、Portage Biotech Inc.涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为209.07%、11.02%、9.30%，振幅较大的相关个股有Chromocell Therapeutics Corporation、Portage Biotech Inc.、Humacyte Inc C/Wts 27/08/2026 (To Pur Com)，振幅分别为34.28%、27.12%、23.85%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。 该公司拥有处于临床前和临床开发各个阶段的项目，其中以肿瘤学为主要重点。 该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。 该公司的产品线主要分为三个领域：眼科产品线，包括开发治疗湿性年龄相关性黄斑变性和糖尿病性黄斑水肿等视网膜疾病的疗法； 肿瘤学产品线，包括具有全新作用模式的 DARPin 候选药物，包括多 DARPin 化合物； 和用于抗癌治疗的免疫肿瘤学产品线。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428266556"}